As clinicians increasingly utilize electronic health records and other point-of-care systems, access to individualized patient data, novel biomarkers and other information for clinical
decision-making is expanding dramatically. At Proventys, we see this trend as a major
opportunity to provide technologies that enable meaningful use of electronic tools and facilitate predictive and personalized approaches to care.

Developing Innovative Solutions for Value-Based Medicine
The direct and indirect costs of chronic disease and catastrophic illness continue to burden the patient population and pose major socioeconomic challenges to the healthcare system as a whole. Across many disease areas, clinicians lack sufficient information and tools required to optimize treatment decisions for individual patients based on their unique clinical and genetic profiles. As a result, patients too often are ordered diagnostics and prescribed therapeutics that fail to prevent disease onset, complications, or progression.

While payers have witnessed some improvement in cost containment through disease management programs, wellness strategies, and pay-for-performance mechanisms, these initiatives have limited impact on critical decisions that take place at the point of care. Healthcare experts continue to point to inefficiencies in care created by reactive approaches to patient conditions and sporadic adherence to evidence-based standards by physicians. Proventys is focused intently on harmonizing the interests of payers, providers, and patients by offering predictive tools in the flow of clinical practice.

The use of personalized, predictive solutions in the clinical workflow will help foster:

• A better understanding of patient risk factors and individualized characteristics
• More consistent comparative assessment of patient treatment options
• Reduced variability of care in key disease areas
• Increased quality of care and a decrease in unnecessary spending